How GPA and Goodpasture Syndrome Cause Interstitial Lung Disease
GPA (granulomatosis with polyangiitis) causes interstitial lung disease through necrotizing granulomatous inflammation and neutrophilic capillaritis driven by ANCA-mediated neutrophil activation, while Goodpasture syndrome (anti-GBM disease) causes pulmonary injury through autoantibodies against type IV collagen in alveolar basement membranes, leading to alveolar hemorrhage rather than classic ILD patterns 1, 2.
Distinct Pathogenic Mechanisms
GPA-Associated ILD Pathogenesis
GPA causes lung injury through multiple overlapping mechanisms:
- ANCA-mediated neutrophil activation: PR3-ANCA (proteinase 3) antibodies, present in 80-90% of GPA cases, activate primed neutrophils, leading to degranulation and release of toxic mediators 3
- Neutrophil extracellular trap (NET) formation: Activated neutrophils release NETs containing chromatin and antimicrobial proteins, perpetuating inflammation and tissue damage 1
- Necrotizing granulomatous inflammation: Formation of granulomas with multinucleated giant cells and microabscesses, characteristic of GPA 4
- Neutrophilic capillaritis: Small vessel inflammation causing direct alveolar and interstitial injury 4
The ILD pattern in GPA differs from typical idiopathic interstitial pneumonias - surgical lung biopsies reveal neutrophilic capillaritis, microabscesses with giant cells, and coexisting usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP) patterns 4.
Anti-GBM Disease (Goodpasture Syndrome) Pathogenesis
Anti-GBM disease operates through a fundamentally different mechanism:
- Autoantibodies against type IV collagen: Specifically target the α3 chain of type IV collagen in alveolar and glomerular basement membranes 5
- Linear IgG deposition: Antibodies bind directly to basement membranes, causing complement activation and inflammatory cell recruitment 6
- Alveolar hemorrhage predominates: Rather than causing fibrotic ILD, anti-GBM disease typically manifests as diffuse alveolar hemorrhage 7
- Pulmonary-renal syndrome: Simultaneous lung and kidney injury is the hallmark presentation 7
Critical distinction: Anti-GBM disease does not typically cause interstitial lung disease in the fibrotic sense - it causes alveolar hemorrhage, which is a different pattern of lung injury 2.
Clinical Patterns and Timing
GPA-ILD Characteristics
ILD in GPA can present in three temporal patterns 8:
- ILD preceding vasculitis diagnosis (22.1% of cases) - particularly in MPO-ANCA positive patients (85.7%)
- ILD at time of AAV diagnosis (66.3% of cases)
- ILD developing during disease course
Radiologic patterns vary by ANCA type 8:
- NSIP pattern: Most common in PR3-ANCA (c-ANCA) positive patients (60.9%)
- UIP pattern: More common in MPO-ANCA (p-ANCA) positive patients (47.7%)
- Subpleural reticular opacities with traction bronchiectasis are characteristic 4
Anti-GBM Disease Presentation
Anti-GBM disease presents acutely with 5:
- Diffuse alveolar hemorrhage causing hemoptysis and hypoxemia
- Rapidly progressive glomerulonephritis
- Symptoms developing over days to weeks, not the chronic progressive course of ILD
Diagnostic Approach
For Suspected GPA-ILD
When ILD is detected in a patient with suspected vasculitis 4, 8:
- Serologic testing: PR3-ANCA and MPO-ANCA - both can be associated with ILD, but MPO-ANCA correlates more strongly with UIP pattern
- High-resolution CT chest: Look for NSIP or UIP patterns, not just nodules or cavities
- Consider surgical lung biopsy when diagnosis is uncertain - reveals characteristic neutrophilic capillaritis and granulomatous inflammation that distinguishes GPA-ILD from idiopathic ILD 4
- Screen for systemic vasculitis features: Sinonasal involvement, glomerulonephritis, peripheral neuropathy 9, 7
For Suspected Anti-GBM Disease
Within 24 hours of presentation with pulmonary-renal syndrome 5:
- Anti-GBM antibody testing - diagnostic hallmark
- ANCA testing - 10-40% have concurrent ANCA positivity ("double-positive disease") 7, 10
- Thoracic imaging - diffuse ground-glass opacities from hemorrhage, not reticular patterns
- Kidney biopsy - shows linear IgG deposits along glomerular basement membrane 6
- Exclude infection before initiating immunosuppression
Common Diagnostic Pitfalls
GPA frequently mimics infection or malignancy 11, 12:
- Cavitary lung masses can appear hypermetabolic on PET scan, suggesting cancer
- Coexisting bacterial infections (Pseudomonas, Haemophilus) are common and can obscure the diagnosis
- Partial response to empiric antibiotics or corticosteroids may delay recognition of underlying vasculitis
- Non-diagnostic biopsies showing only inflammation without characteristic granulomas
The key distinguishing feature: Persistent or progressive disease despite appropriate antimicrobial therapy, combined with ANCA positivity and systemic features, should trigger consideration of GPA 11, 12.
Treatment Implications
GPA-ILD Treatment
Follow standard AAV remission induction protocols 9, 13:
- Rituximab preferred over cyclophosphamide for remission induction
- Reduced-dose glucocorticoid regimen (starting with pulse methylprednisolone 3 grams total, then rapid taper)
- Maintenance therapy with rituximab for 24-48 months
ILD-specific considerations: The presence of ILD does not fundamentally change AAV treatment, but requires pulmonary monitoring during therapy 14.
Anti-GBM Disease Treatment
Requires urgent, aggressive therapy 5:
- Plasmapheresis (plasma exchange) - essential component, unlike in isolated AAV
- Glucocorticoids plus cyclophosphamide (rituximab as alternative)
- Treatment must begin within 24 hours to preserve renal function
- Maintenance therapy not required unless concurrent ANCA positivity present
Double-positive disease (anti-GBM + ANCA): Treat as anti-GBM disease with plasma exchange, but continue maintenance immunosuppression as for AAV 9, 13, 10.